【24h】

Point-of-care protein sensing platform based on immuno-like membrane with molecularly-aligned nanocavities

机译:基于具有分子排列的纳米腔的免疫样膜的即时护理蛋白质感测平台

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This paper presents the ability of the novel point-of-care protein sensing platform based on immune-like polymer membrane to separate and sense target analytes in human serum samples using the molecularly-aligned nanocavities. The separation performance of the developed membrane, which is substantially affected by surface chemistry and physics, can be enhanced by alignment of the template molecules. The developed biomimetic membrane with aligned molecular nanocavities can be synthesized and integrated with microfluidic biochips as point-of-care sensing platforms. The measurement results showed that the specific adhesion forces of the developed highly-aligned nanocavities on the immuno-like membranes are comparable to the interaction forces between CRP and biological CRP antibodies. The biomimetic polymer membrane works as antibody to catch specific proteins in complex biofluids within 110. s. The proposed approach is an adaptive technological platform because it facilitates cost-effective mass production and can be applied to a wide range of protein biomarkers.
机译:本文介绍了基于免疫样聚合物膜的新型即时护理蛋白质感测平台使用分子排列的纳米腔分离并感测人血清样品中目标分析物的能力。可以通过模板分子的排列来增强显影膜的分离性能,该分离性能基本上受表面化学和物理影响。可以合成具有对准的分子纳米腔的仿生膜,并将其与微流控生物芯片集成为即时护理感测平台。测量结果表明,已开发的高度对齐的纳米腔在免疫样膜上的比粘附力与CRP和生物CRP抗体之间的相互作用力相当。仿生聚合物膜可作为抗体在110秒内捕获复杂生物流体中的特定蛋白质。所提出的方法是一种自适应技术平台,因为它可以促进具有成本效益的大规模生产,并且可以应用于广泛的蛋白质生物标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号